AAVATAR Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$3.68M
- Investors
-
12
AAVATAR Therapeutics General Information
Description
Developer of an intelligent gene therapy platform intended to treat rare diseases. The company's technology utilizes artificial intelligence capsid engineering, machine-learning-based biological analysis, recombinant AAV production, in vivo screening, next-generation sequencing, and predictive modeling, enabling pharmaceutical companies to deliver gene therapies precisely to targeted tissues while reducing side effects and improving treatment efficiency.
Contact Information
Website
www.aavatartps.comCorporate Office
- Room 1023, Building B 540
- Misa-daero, Hyundai Knowledge Industry Center Hangang Misa 2nd
- Hanam, Gyeonggi 12925
- South Korea
Corporate Office
- Room 1023, Building B 540
- Misa-daero, Hyundai Knowledge Industry Center Hangang Misa 2nd
- Hanam, Gyeonggi 12925
- South Korea
AAVATAR Therapeutics Timeline
AAVATAR Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 30-Sep-2026 | $3.68M | Completed | Pre-Clinical Trials | ||
| 8. Accelerator/Incubator | 01-Jun-2026 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 01-May-2026 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC (Series A) | 23-Oct-2025 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC (Series A) | 07-Nov-2023 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC | 01-Aug-2022 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 01-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 01-May-2021 | Completed | Pre-Clinical Trials | |||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AAVATAR Therapeutics Patents
AAVATAR Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12480098-B1 | Adeno-associated virus variant | Active | 18-Oct-2024 | ||
| US-20260109956-A1 | Adeno-associated virus variant | Pending | 18-Oct-2024 | ||
| EP-4768500-A1 | Adeno-associated virus variants | Pending | 18-Oct-2024 | ||
| EP-4768500-A4 | Adeno-associated virus variants | Pending | 18-Oct-2024 | ||
| WO-2026084101-A1 | Adeno-associated virus variants | Pending | 18-Oct-2024 | C12N7/00 |
AAVATAR Therapeutics Signals
AAVATAR Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HB Investment | Venture Capital | Minority | ||
| IBK Changgong | Accelerator/Incubator | |||
| Regent Partners (Seoul) | Venture Capital | Minority | ||
| Shinhan Capital | Venture Capital | Minority | ||
| Smilegate Investment | Venture Capital | Minority |
AAVATAR Therapeutics FAQs
-
When was AAVATAR Therapeutics founded?
AAVATAR Therapeutics was founded in 2020.
-
Where is AAVATAR Therapeutics headquartered?
AAVATAR Therapeutics is headquartered in Hanam, South Korea.
-
What is the size of AAVATAR Therapeutics?
AAVATAR Therapeutics has 18 total employees.
-
What industry is AAVATAR Therapeutics in?
AAVATAR Therapeutics’s primary industry is Drug Delivery.
-
Is AAVATAR Therapeutics a private or public company?
AAVATAR Therapeutics is a Private company.
-
What is AAVATAR Therapeutics’s current revenue?
The current revenue for AAVATAR Therapeutics is .
-
How much funding has AAVATAR Therapeutics raised over time?
AAVATAR Therapeutics has raised $7.39M.
-
Who are AAVATAR Therapeutics’s investors?
HB Investment, IBK Changgong, Regent Partners (Seoul), Shinhan Capital, and Smilegate Investment are 5 of 12 investors who have invested in AAVATAR Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process